[Development of synergies and partnerships on rare diseases: model of a scientific cooperation foundation].
作者信息
Lévy Nicolas
机构信息
Hôpital Broussais, GIS-institut des maladies rares, plate-forme maladies rares, 75014 Paris, France.
出版信息
Presse Med. 2012 May;41 Suppl 1:S23-5. doi: 10.1016/j.lpm.2012.02.029. Epub 2012 Apr 6.
PMID:22483766
Abstract
摘要
相似文献
1
[Development of synergies and partnerships on rare diseases: model of a scientific cooperation foundation].[罕见病协同效应与伙伴关系的发展：一个科学合作基金会的模式]
Presse Med. 2012 May;41 Suppl 1:S23-5. doi: 10.1016/j.lpm.2012.02.029. Epub 2012 Apr 6.
2
Alzheimer's disease public-private partnerships: A landscape of the global nonprofit community.阿尔茨海默病公私合作伙伴关系：全球非营利组织界概况
Alzheimers Dement. 2013 Jul;9(4):466-71. doi: 10.1016/j.jalz.2013.05.1761.
3
[Interest in partnerships around the Mediterranean basin for rare diseases].对地中海盆地周边罕见病合作关系的关注
Presse Med. 2012 May;41 Suppl 1:S51-4. doi: 10.1016/j.lpm.2012.02.033. Epub 2012 Mar 28.
4
[Mediterranean region debate-what are the existing partnerships? What are the ones missing?].[地中海地区辩论——现有的伙伴关系有哪些？缺少哪些伙伴关系？]
Med Sci (Paris). 2014 Apr;30 Spe(1):40-6. doi: 10.1051/medsci/201430s110. Epub 2014 Apr 14.
5
Europe's innovation hub finally KICs off.欧洲的创新中心终于启动了。 （注：原句中“KICs off”有误，正确的应该是“kicks off”，意为“开始、启动” ）
Nature. 2011 Feb 24;470(7335):450. doi: 10.1038/470450a.
6
Academia-pharma partnerships for novel drug discovery: essential or nice to have?学术界与制药公司合作进行新药研发：是必不可少还是可有可无？
Expert Opin Drug Discov. 2017 Jun;12(6):537-540. doi: 10.1080/17460441.2017.1318124. Epub 2017 Apr 17.
7
Funding bodies should foster partnerships between industry and academia.资助机构应促进产业界与学术界之间的合作关系。
Nat Rev Cancer. 2021 Feb;21(2):65-66. doi: 10.1038/s41568-020-00326-w.
8
The CNCCS, a benchmark Italian consortium for bioeconomy and an opportunity for the Istituto Superiore di Sanità.CNCCS是意大利生物经济领域的一个标杆性财团，也是高等卫生研究院的一个机遇。
Ann Ist Super Sanita. 2012;48(2):115-6. doi: 10.4415/ANN_12_02_01.
9
Allocation of control rights and cooperation efficiency in public-private partnerships: theory and evidence from the Chinese pharmaceutical industry.公私合营伙伴关系中的控制权分配与合作效率：来自中国制药行业的理论与证据
Int J Health Care Finance Econ. 2009 Jun;9(2):169-82. doi: 10.1007/s10754-009-9063-5. Epub 2009 Apr 10.
10
A transformative program, ahead of its time.
Nurs Outlook. 2014 Nov-Dec;62(6):482-90. doi: 10.1016/j.outlook.2014.09.004. Epub 2014 Oct 23.
Zotero 插件